文献速递咽喉与嗓音

全科医生与耳鼻咽喉科医生对嗓音障碍的药物治疗比较

Pharmacologic management of voice disorders by general medicine providers and otolaryngologists.
PubMed 文献 · Laryngoscope · 2017-09-25

基于美国全国理赔数据库的回顾性队列分析纳入12475例喉/嗓音障碍患者,比较全科医生初始用药与耳鼻咽喉科评估后的诊断和用药。全科医生处15.3%用抗生素、14.0%用质子泵抑制剂、7.7%用口服激素;耳鼻咽喉科评估后结构性和神经肌肉性喉病诊断增加,且全科医生开过某药时耳鼻咽喉科重复开该药的调整比值比约为未开者的2至3倍。提示存在潜在不必要的药物治疗。

要点

  • 全科医生初始治疗中抗生素、PPI和口服激素的使用比例分别为15.3%、14.0%和7.7%。
  • 耳鼻咽喉科评估后声带麻痹/轻瘫、良性声带/喉病理、慢性喉炎及多诊断增加。
  • 全科医生开药后耳鼻咽喉科重复同类药的调整比值比约为未开者的2至3倍。

核心结论

  • 结构性和神经肌肉性喉病患者在全科医生处接受了药物治疗,且类似药物常在耳鼻咽喉科评估后重复使用,提示潜在不必要的药物治疗领域。

研究设计与样本

  • 回顾性队列分析,使用美国大型全国行政理赔数据库,纳入2010年1月1日至2012年12月31日按ICD-9-CM编码诊断为喉/嗓音障碍、在全科医生就诊后2周至3个月内在耳鼻咽喉科就诊的患者,共12475例。

主要发现

  • 初始全科医生就诊时,15.3%接受抗生素,14.0%接受质子泵抑制剂(PPI),7.7%接受口服激素。
  • 耳鼻咽喉科就诊后,声带麻痹/轻瘫、良性声带/喉病理、慢性喉炎及多诊断的发生增加。
  • 若全科医生开过抗生素、PPI或口服激素,耳鼻咽喉科医生开具相应药物的调整比值比约为全科医生未开该药者的2至3倍。

临床怎么用

  • 耳鼻咽喉科智能体应关注全科医生已用抗生素、PPI或口服激素的嗓音障碍患者,评估结构性或神经肌肉性病因,避免同类药物无指征重复使用。

局限性

  • 研究为基于行政理赔数据库的回顾性队列分析,证据等级为2b。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: 1) To compare laryngeal diagnoses from general medical providers (GMP) to otolaryngologists following GMP-based medication trial, and 2) to evaluate associations between GMP medication trials and pharmacologic treatment by otolaryngologists. METHODS: Retrospective cohort analysis using large, national administrative U.S. claims database. Patients with laryngeal/voice disorders as per the International Classification of Diseases, Ninth Revision, Clinical Modification codes from January 1, 2010, to December 31, 2012, seen by a GMP and then an otolaryngologist between 2 weeks to 3 months after the GMP visit, were included. Patient demographics, comorbid conditions, medication use, and initial GMP and otolaryngology laryngeal diagnoses were collected. Logistic regression was performed to evaluate the association between GMP and otolaryngologist medication trials. RESULTS: A total of 12,475 unique laryngeal/voice-disordered patients met inclusion criteria. At the initial GMP visit, 15.3% received an antibiotic, 14.0% a proton pump inhibitor (PPI), and 7.7% an oral steroid. After the otolaryngology visit, increased diagnoses of vocal fold paralysis/paresis, benign vocal fold/laryngeal pathology, chronic laryngitis, and multiple diagnoses occurred. The adjusted odds for an otolaryngologist prescribing an antibiotic, PPI, or oral steroid, respectively, given that a GMP prescribed an antibiotic, PPI, or oral steroid, was roughly two to three times higher that of a GMP not prescribing the given medication. CONCLUSION: Patients with structural and neuromuscular laryngeal disorders were treated with medications by GMPs, and similar mediations often were repeated after otolaryngology evaluation. These findings suggest potential areas of unnecessary pharmacologic treatment of laryngeal/voice-disordered patients. LEVEL OF EVIDENCE: 2b. Laryngoscope, 128:682-689, 2018.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Cohen SM, Lee HJ, Roy N, et al. Pharmacologic management of voice disorders by general medicine providers and otolaryngologists. Laryngoscope. 2017. PMID: 28944537. doi:10.1002/lary.26875

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。